FDA Proposes Rule to Classify OTC Quinine-Based Malaria Medications as Misbranded

Summary

The Food and Drug Administration (FDA) is proposing a rule that would classify over-the-counter (OTC) quinine-based medications for treating and preventing malaria as misbranded and not generally recognized as safe, following a review of safety data. This move aims to protect consumers from potential harm from these medications.